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Objectives: to investigate the prevalence of intermittent claudication (IC) in an unselected population of nearly 20 000
individuals between 40 and 69 years of age.
Design: epidemiologic investigation of residents in Nord-Trùndelag County, Norway.
Material and Methods: between 1995 and 1997, all residents 20 years of age or older in Nord-Trùndelag County, Norway,
were invited to attend the HUNT Study. A total of 19 748 participants between 40 and 69 years of age responded to
questions related to the symptoms of intermittent claudication.We estimated the prevalence of IC based on these questions.
Results: the age-adjusted prevalence of intermittent claudication in the total population was 1.1% for men and 1.2% for
women. We found an increase in the prevalence of IC by age, however, no sex differences were observed.
Conclusion: the prevalence of intermittent claudication increased gradually by age. However, in contrast to previous
reports, there was no difference by sex.
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Introduction
Intermittent claudication (IC) is a manifestation of
generalized atherosclerosis often associated with life
threatening cardiac- and cerebro-vascular disease.
Intermittent claudication may not be fatal, but the
disease represents a heavy burden of disability and
discomfort.1 In western societies, the aging of the
population will result in an increasing number of
patients with IC. The increasing prevalence of type II
diabetes will also contribute to increase the impact of
this disease.1±3
The history of IC is usually characterized by leg
pain during exercise which is relieved by rest.
Although several questionnaires have been developed
for epidemiological studies, the TASC Consensus
document concluded that for self reporting of symp-
toms the Edinburgh Claudication Questionnaire has
shown reasonable predictive capability.1 The ques-
tions used to identify suspected cases of IC in this
study were therefore made in accordance with these
recommendations. Our objective was to estimate the
prevalence of IC in a population of nearly 20 000 indi-
viduals between 40 and 69 years of age.4
Material and Methods
Between 1995 and 1997, the Nord-Trùndelag Health
Survey (the HUNT Study) in Norway was conducted
as a collaboration between the National Health
Screening Service, the National Institute of Public
Health, and the Norwegian University of Science
and Technology. All residents aged 20 years or more
were invited to participate. The participants were
asked to fill in a questionnaire which was mailed
together with the invitation, and to attend a physical
examination. The examination included measure-
ments of height, weight, blood pressure and a blood
sample was collected. A second questionnaire includ-
ing the questions regarding IC was handed out at the
examination and the participants were asked to fill
in this questionnaire at home and return it in the
included pre-stamped envelope. The two question-
naires covered more than 200 health related questions,
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including five specific questions on intermittent
claudication (Table 1).
A total of 66 140 individuals attended the study,
yielding 71.2% of all those invited. All participants in
the age group 40±69 years who completed the ques-
tions on IC were included in this study, yielding 9405
men and 10 343 women. Persons older than 69 years of
age were not included in the investigation because of
practical problems for this group to fill in a relatively
complicated questionnaire and to attend the physical
examination.
To identify cases of IC we used four questions in
conformity with the consensus criteria formulated
during the work with the Trans Atlantic Inter-Society
Consensus on management of peripheral arterial dis-
ease (TASC).1 Briefly, by using these questions, the
participants were suspected of having IC if they
(1) indicated pain in one or both legs during walking;
(2) the pain was located to the calf; (3) the pain dis-
appeared after a period of rest; and (4) the pain was
absent at rest.
Age adjustment for the prevalence of IC in the study
population was done using the direct age standardiz-
ing method with the corresponding total population
of the HUNT study, 40±69 years of age as the reference
standard.5
To investigate the differences in prevalence bet-
ween men and women, we also constructed a simple
prevalence ratio (PR) between men and women, and
estimated an age-adjusted precision of this ratio by
95% confidence intervals (C.I.).5
All statistical analyses were performed using SPSS
for Windows (Release 10.07, Copyright # SPSS Inc.,
1989±2002). The investigation was approved by the
local ethics committee.
Results
The age-adjusted prevalence of intermittent claudica-
tion in the total study population was 1.2% for women
and 1.1% for men (Table 2); yielding a total crude
prevalence of 1.2%. We observed a gradual increase
of the prevalence of IC with age in both men and
women (Fig. 1). Between the age group 40±44 years
to 65±69 years the prevalence difference was nearly 8-
fold, and this pattern was similar for men and women.
The prevalence ratios (Table 3) showed no substantial
sex difference in any age group, and the total preva-
lence sex ratio was 1.0 (95% C.I. 0.8±1.3).
Table 1. The questionnaire on intermittent claudication (IC) in the
HUNT-study.
Have you experienced pain
in one or both legs during
walking?
Yes & No &
Where is the pain localized? Foot & Calf & Thigh & Hip &
Does the pain regress
after a period of rest?
Yes & No &
Is the pain present at rest? Yes & No &
Can you walk further than
50 meters?
Yes & No &
Table 2. The prevalence of intermittent claudication (IC) by self reporting of symptoms.
Age Men Women
Intermittent
claudication
Participants Prevalence
(%)
Intermittent
claudication
Participants Prevalence
(%)
40±44 8 1858 0.4 7 2158 0.3
45±49 11 1935 0.6 12 2178 0.6
50±54 11 1819 0.6 23 2020 1.1
55±59 14 1351 1.0 21 1447 1.5
60±64 27 1188 2.3 18 1227 1.5
65±69 37 1254 3.0 41 1313 3.1
Total 108 9405 1.1a 122 10343 1.2a
a Age standardized prevalence by direct age-standardization.
Fig. 1. The prevalence of intermittent claudication (IC) in the dif-
ferent age groups of a population including 9.405 men and 10 343
women between 40 and 69 years of age.
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Discussion
The prevalence of diseases related to atherosclerosis
may vary significantly from one country to another.
We therefore wanted to investigate the prevalence of
intermittent claudication in Nord-Trùndelag county
including a part of the population of nearly 20 000
individuals. We constructed a set of questions in con-
formity with guidelines forming the basis for the
TASC document to ascertain cases of IC. This ques-
tionnaire is highly specific in excluding normal indi-
viduals, but only moderately sensitive in detecting
those with IC compared with a physician's assessment
of signs and symptoms.1 However, the questionnaire
is convenient for epidemiologic investigations on IC
in a large population. We found an age-adjusted
prevalence of 1.1% in men and 1.2% in women
among individuals 40±69 years of age. Since the
questions on IC were handed out at the physical
examination, this might have excluded some subjects
unable to attend because of leg pain. Therefore the
prevalence of IC could have been underestimated.
The questionnaire also included pain in the thigh
and hip as well as the calf. Objects indicating hip
and thigh pain only were however excluded. First of
all individuals with ischaemic hip and thigh pain
represent a minority of patients with IC. Further,
those with ischaemic hip and thigh pain usually
also have leg pain. Finally, including objects with
hip and thigh pain only would have included diseases
like low back pain, hip athrosis etc. decreasing
the specificity and the positive predictive value of
the test.
In Norway, as in most other western countries, the
elderly population is expected to increase over the
next 30 years due to the `` baby boom'' generation
born between 1945 and 1955 following the second
World War.2 The population over 67 years of age in
Norway is expected to nearly double, reaching 0.9 to
1.2 million persons in 2050.2 Also, the incidence of
diabetes is increasing in the western world.1 The
aging of the population combined with an increased
incidence of diabetes will most likely result in an
increased number of persons with IC as well as more
serious leg ischaemia leading to an increased need for
vascular procedures. Without proper planning and
resource allocation, the consequences could be that
the patients will not receive appropriate treatment
due to lack of financial resources.1,3 These prognoses
must be taken into careful consideration for future
health care planning.3
Previous reports from the 1950's and the 1960's
indicated that the male prevalence of IC was higher
than for females.6±9 In the present study, however, the
prevalence in women did not differ from that in men
(Prevalence ratio 1.0, 95% C.I. 0.8±1.3). This result is
in accordance with recent findings, indicating that a
real change has taken place over this time period.1,10
The previously reported sex difference has been attrib-
uted to the effect of sex hormones on lipoproteins.1
The prevalence of IC in men over 60 years of age has
been relatively stable since the 1950's.8,11±14 There has,
however, been a marked increase in smoking among
women. Taking the positive association between
smoking and IC into consideration, smoking is likely
to be an important cause of the increased prevalence
of IC in women.1,6,9,10
Prevalence estimates for IC in previous studies vary
from 0.4±14.4%.1 Compared to most previous reports,
we observed low prevalence estimates for men in all
age groups under the age of 60. However, among
women in the same age groups, we found a higher
prevalence than in most other studies.1,7,8,11±14 In age
groups over 60 years, the prevalence among men was
in accordance with other studies, but for women, the
prevalence in our study was substantially higher than
in previous reports.1
In summary, the age-adjusted prevalence of inter-
mittent claudication was 1.1% among men and 1.2%
among women between 40 and 69 years of age. We
observed a gradual increase in prevalence by age,
but in contrast to previous findings in the 1950's and
1960's there were no differences in prevalence by sex.
The expected increase in the number of patients with
intermittent claudication in the years to come will
represent a major challenge to the health care system
in most western countries, and there will most
likely be an increased need for treatment of vascular
diseases.
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Table 3. Prevalence ratio between men and women.
Age group PRa 95% C.I.
40±44 0.8 (0.3±2.1)
45±49 1.0 (0.4±2.2)
50±54 1.9 (0.9±3.8)
55±59 1.4 (0.7±2.7)
60±64 0.7 (0.4±1.2)
65±69 1.1 (0.7±1.6)
Total 1.0 (0.8±1.3)
a Prevalence ratio with 95% confidence interval (C.I.).
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